	Sequential Use of Trastuzumab Deruxtecan and Sacituzumab Govitecan in Patients with Breast Cancer: A Pharmacological Approach to Support the Clinical Rationale. Drugs Del Re M, Inglese E, Bria E, Blok EJ, Mathijssen RHJ, Curigliano G, Danesi R. PMID: 41931218 [PubMed - as supplied by publisher]
	Statins and postmenopausal breast cancer risk; results from the KARMA cohort. Cancer Causes Control Klintman M, Rosendahl AH, Johannesen BR, Cronin-Fenton D, Eriksson M, Czene K, Hall P, Borgquist S. PMID: 41931132 [PubMed - indexed for MEDLINE]
	Invasive lobular and ductal breast cancers: a systematic review and metanalysis in association with BRCA1/2 mutation status. Eur J Cancer Corso G, Andreon C, La Vecchia C, Bottazzoli EI, Abruzzese G, Favilla K, Citterio O, Spoldi E, Di Silvestre S, De Scalzi AM, Polizzi A, Meduri E, Trapani D, Nicosia L, Pesapane F, Bossi D, Brogi E, Shen S, Mukhtar R, Criscitiello C, Veronesi P, Gandini S, Magnoni F, Curigliano G. PMID: 41930855 [PubMed - as supplied by publisher]
	Fully Automated Stain Quantification Framework for IHC Whole Slide Images in Breast Cancer. Technol Cancer Res Treat Yin T, Lifrange F, Denis Z, de Caluwé A, Buisseret L, Catteau X, Legros C, Reynaert N, Dhont J. PMID: 41930704 [PubMed - indexed for MEDLINE]
	Results and Exploratory Biomarker Analyses of a Phase II Study CHANGEABLE: Combination of PD-1 Inhibitor and Niraparib in GErm-Line-mutAted Metastatic Breast Cancer. MedComm (2020) Zhang J, Du Y, Meng Y, Jin Y, Lin M, Shao X, Liu X, Mu Y, Liu Y, Hu Z. PMID: 41930344 [PubMed]
	How artificial intelligence applied to digital pathology could guide treatment personalization in breast cancer. ESMO Real World Data Digit Oncol Ruelle T, Grinda T, Del Mastro L, Lacroix-Triki M, Pistilli B, Gessain G. PMID: 41930306 [PubMed]
	Second-line therapies after CDK4/6 inhibitor failure in HR-positive/HER2-negative metastatic breast cancer patients: real-world data from the HERMIONE-13 study. ESMO Real World Data Digit Oncol Cazzaniga ME, Cogliati V, Rossi E, Paris I, Borella F, Moretti G, Garrone O, Pistelli M, Palumbo R, Ferro A, Vici P, De Giorgi U, Madaro S, Coltelli L, Giordano M, Gambaro AR, Nicoletti SVL, Zustovich F, Landucci E, Gamucci T, Pepe FF, Galimberti S, Capici S. PMID: 41930299 [PubMed]
	Multi-Scale Transcriptomic Sequencing Data Analysis Reveals LINC00467 is Associated with Malignant Progression in Breast Cancer: An In Silico and In Vitro Study. Oncol Res Zha H, Li C, Chen J, Bo H, Hu Z, Qin Z, Guo J, Yuan J. PMID: 41930179 [PubMed - indexed for MEDLINE]
	Efficacy and Mechanisms of CDK4/6 Inhibitors in Breast Cancer: Advancing Targeted Therapeutic Strategies. Oncol Res Patwekar M, Patwekar F, Kari ZA, Zain MRAM, Mohammed A, Sharma R. PMID: 41930171 [PubMed - indexed for MEDLINE]
	Red Breast Syndrome and Early Postoperative Complications in Immediate Prepectoral Implant-Based Reconstruction Using BraxonÂ® Acellular Dermal Matrix: A Retrospective Cohort Study. Cureus Oweis R, Jan SM, Luttrell D, In 't Hout B, Caldon L, Masudi T. PMID: 41930076 [PubMed]
	Symptoms Experienced by Breast Cancer Patients Before, During and After Chemotherapy: A Systematic Review. Int J Womens Health Cao Y, Lee K, Yusuf A, Chen ST, Dong X, Li L, Lim PY. PMID: 41929936 [PubMed]
	Artificial intelligence-assisted breast ultrasound: modest AUROC improvement and shorter interpretation time without significant change in diagnostic accuracy. Front Radiol Kwon H, Kim SM, Oh SH, Jang M, Kim MG, Bae HM, Choi SI, Cho SM, Kim Y, Jung G, Lee HJ, Kim SY. PMID: 41929405 [PubMed]
	Infections in Implant-Based Breast Reconstruction: A Systematic Review of Risk Factors, Prevention, and Salvage Strategies. Aesthet Surg J Open Forum Ragaini EM, Ferrari C, Comunian R, Cavallero MF, Vaccari S, Bavaro DF, Klinger F, Vinci V, Di Giuli R. PMID: 41928779 [PubMed]
	miRNAs as Theragnostic Markers for PARP Inhibitor Resistance in Breast Cancer: A Systematic Review. Curr Cancer Drug Targets Molavand M, Golchin A, Yousefi B. PMID: 41928642 [PubMed - as supplied by publisher]
	Treatment for metastatic triple-negative breast cancer with homologous recombination deficiency: a Bayesian network meta-analysis. BMC Cancer Xu H, Wang Y, Sa Q, Zhou Y, Wang J, Xu B. PMID: 41928156 [PubMed - as supplied by publisher]
	Prediction model to prevent axillary surgery using axillary US and MRI in early breast cancer. Eur Radiol Xie H, Wang X, Guo W, Wu Y, Chen R, Zhao X, Huang J, Zhang H, Wu C, Chen J. PMID: 41927980 [PubMed - as supplied by publisher]
	Multimodal Imaging-Based Prediction of Pathological Complete Response After Neoadjuvant Chemotherapy for Breast Cancer. J Imaging Inform Med Zhang W, Sun W, Li Y, Zhu Y, Li B. PMID: 41927823 [PubMed - as supplied by publisher]
	Targeting the neuro-immune crosstalk in breast cancer brain metastases. J Immunother Cancer Zou Y, Wu J, Yuan Z, He X, Tang H. PMID: 41927345 [PubMed - indexed for MEDLINE]
	Feedback from wearable devices accelerates recovery after breast cancer surgery. Eur J Surg Oncol Latif A, Al Janabi N, Joshi M, Che Bakri NA, Kwasnicki RM, Fusari G, Shepherd L, Darzi A, Leff DR. PMID: 41926867 [PubMed - as supplied by publisher]
	Improving CTV(boost) delineation after preoperative systemic therapy in breast cancer using deformable PET/CT registration. Breast Kemmeugne J, Gallay L, Morland D, Hotton J, Jouannaud C, Merrouche Y, Papathanassiou D, Reyal F, Ndéo Sene M, Torielli P, Vignot S, Guilbert P, Beddok A. PMID: 41926859 [PubMed - as supplied by publisher]

Articles 1 - 20 / 216275

Page 1 of 10814



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy